Ganga Ram Chaudhary*,
Pratibha Bansal,
Navneet Kaur and
S. K. Mehta
Department of Chemistry & Centre of Advanced Studies in Chemistry, Panjab University, Chandigarh-160014, India. E-mail: grc22@pu.ac.in; Fax: +91-172-2545074; Tel: +91-172 2534406
First published on 30th September 2014
CuO nanoparticles (NPs) of 17–22 nm size have been synthesized in very high yield in 4 minutes using a microwave and water as medium. The obtained NPs have been characterized by FTIR, XRD and TEM. CuO NPs have been used as a nanocatalyst to carry out the synthesis of xanthenes in solvent free conditions. They exhibit good catalytic activity with excellent yield. The main features of CuO NPs as catalyst in the synthesis of xanthenes are reduced reaction time, higher yields, ease of product isolation, economic availability of catalyst, simple procedure, and no harmful byproducts. The spent heterogeneous catalyst has been recovered by simple filtration and reused for multiple cycles.
Organic transformations using heterogeneous catalyst under solvent free condition has gained great importance, due to minimum pollution and easy work up conditions.2–5 In recent years, much attention has been given to the synthesis of xanthene derivatives.6–8
Xanthenes and its derivatives are very important class of heterocyclic compounds because of their wide range of biological and pharmaceutical properties.9 In addition, these compounds are widely used as dyes,10 fluorescent materials for sensing of biomolecules11 and for antiviral activity.12 These compounds are also utilized as antagonists for paralyzing action of zoxazolamine and in photodynamic therapy.13 Due to their wide range of applications, a wide variety of methods for the preparation of the xanthenes have been reported. Instead of Lewis acid14–17 as catalyst, which is associated with harsh experimental conditions such as anhydrous condition, high temperature, prolonged reaction time, expensive, harmful and difficult to handle reagents, low yield, difficult work up, use of nanocatalyst has been encouraged in recent times.18,19 There are successful attempts of xanthenes synthesis using ZnO18 and Fe3O4 nanocatalyst.19 However, in both cases quantity of catalyst required is large, moreover it takes more time to produce xanthenes with lesser yield.
Among various metal oxides NPs, in the present study we have chosen CuO NPs as promising candidate due to low cost, abundant resources, non-toxicity and easy preparation in various shapes of nanosized dimensions. CuO NPs has been widely used in electrochemical cells,20 gas sensors,21 photovoltaic cells,22 thermoelectric materials,23 nanofluids and for photocatalysis.24,25 The methods to synthesize CuO nanomaterials are diverse, such as electrochemical deposition, alcohothermal, solid-state reaction and sol–gel.26–29 However above mentioned methods for synthesis of CuO NPs had some disadvantage such as time consuming, expensive, pollution causing and low yields. To overcome all the problems we have chosen microwave (MW) synthesis over conventional synthesis. It takes just 4 min to synthesis CuO NPs of 17–22 nm size. This method is economical both in terms of energy consumption and time.
The purpose of the present work is to explore the utility of CuO NPs as catalyst in synthesis of xanthenes under solvent free conditions. In the present work, CuO NPs are acting as efficient heterogeneous catalyst in synthesis of xanthenes in terms of short reaction time, easy work up, excellent yield, enhanced energy efficiency, cost effective and no harmful by-products.
XRD is powerful technique to analyze the structure of the material and weather the substance is crystalline or amorphous, as for crystalline substance well defined peaks are observed in XRD. Diffraction peaks for CuO NPs were obtained with (hkl) values as (110), (−111), (111/200), (−202), (020), (202), (−113), (022/−311), (113/220), (311), (004/−222) which are found to be same for single phase CuO NPs with a monoclinic (card JCPDS 72-0629)32 as shown in Fig. 2. No peaks of impurity was found in XRD pattern. Particle size was calculated from FWHM of reflection (111/200) of monoclinic CuO structure using Debye Scherrer formula (eqn (1)). The particle size was found to be ∼18 nm.
For determining the morphology, TEM micrograph of CuO NPs was taken. As illustrated from the Fig. 3, NPs were almost spherical in shape, well dispersed and narrow range of size distribution (17–22 nm).
The particle size distribution of synthesized CuO NPs has been estimated by particle size analyzer (PSA). Fig. 4 shows the typical particle size distribution graph which reveals that the average diameter of synthesized CuO NPs is 25 nm. The polydispersity index (PDI) of synthesized nanoparticles is found to be 0.20 that confirms the monodispersity of synthesized NPs.
R = H, Cl, Br, NO2, CN, OCH3 |
S.no. | Amount of catalyst (mg) | Time (min)/% yield |
---|---|---|
1. | Nil | 60/nil |
2. | 2 | 25/60 |
3. | 3 | 22/68 |
4. | 4 | 20/72 |
5. | 5 | 18/80 |
6. | 6 | 17/95 |
7. | 7 | 16/95 |
8. | 8 | 14/89 |
9. | 8 | 16/95 |
S.no. | Benzaldehyde | Product (xanthenes) | Time (min) | Yield (%) | Melting point | Ref. |
---|---|---|---|---|---|---|
a Their melting points are compared with reported values. Amount catalyst used was 7 mg. | ||||||
4a | ![]() |
![]() |
14 | 89 | 202–204 | 42 |
4b | ![]() |
![]() |
18 | 92 | 230–231 | 42 |
4c | ![]() |
![]() |
15 | 87 | 241–243 | 40 |
4d | ![]() |
![]() |
9 | 90 | 219–221 | 42 |
4e | ![]() |
![]() |
12 | 89 | 183–184 | 40 |
4f | ![]() |
![]() |
13 | 90 | 230–232 | 40 |
4g | ![]() |
![]() |
13 | 89 | 240–241 | 40 |
4h | ![]() |
![]() |
9 | 95 | 261–262 | 40 |
4i | ![]() |
![]() |
20 | 85 | 214–215 | 40 |
5a | ![]() |
![]() |
16 | 95 | 181–183 | 40 |
5b | ![]() |
![]() |
23 | 84 | 227–229 | 40 |
5c | ![]() |
![]() |
25 | 82 | 203–204 | 40 |
5d | ![]() |
![]() |
14 | 93 | 310–312 | 40 |
5e | ![]() |
![]() |
15 | 86 | 211–212 | 42 |
5f | ![]() |
![]() |
15 | 83 | 287–289 | 40 |
5g | ![]() |
![]() |
16 | 87 | 296–297 | 40 |
5h | ![]() |
![]() |
13 | 90 | 218–219 | 40 |
![]() | ||
Fig. 5 Recycling ability of CuO NPs for 5a in Table 2. |
Name of catalyst | Amount of catalyst (mg) | Time/yield in (%) | Solvent/condition | Ref. |
---|---|---|---|---|
K5CoW12O40·3H2O | 64 | 2 (h)/91 | Solvent free/125 °C | 36 |
Succinimide-N-sulfonic acid | 10 | 35 (min)/92 | Solvent free/80 °C | 37 |
Sulfamic acid | 9.7 | 8 (h)/93 | Solvent free/125 °C | 38 |
Tungstophosphoric acid/zirconia composites | 50 | 1 (h)/99 | Solvent free/130 °C | 39 |
Iodine | 25.38 | 2.5 (h)/90 | Solvent free/90 °C | 40 |
Fe(HSO4)3 | 35 | 4 (h)/85 | DCM | 41 |
Amberlyst-15 | 10 | 2 (h)/94 | Solvent free/125 °C | 42 |
Functionalized mesoporous materials | 20 | 6 (h)/80 | DCM/25 °C | 43 |
ZnO NPs (24 nm) | 10 | 28 (min)/87 | Solvent free/80 °C | 18 |
Fe3O4 NPs (40–50 nm) | 20 | 30 (min)/88 | Solvent free/80 °C | 19 |
CuO NPs (17–22 nm) | 7 | 16 (min)/95 | Solvent free/80 °C | This work |
![]() | (1) |
where K is shape factor, λ is the X-ray wavelength, β is the full width at half the maximum intensity (FWHM), θ is Braggs angle and D is the mean size of particle. Fourier transform infrared (FTIR) spectra was obtained on a Perkin Elmer FTIR spectrophotometer in the frequency range of 4000–1000 cm−1 using KBr plates with 100 number scans and 4 cm−1 spectral resolution. Transmission electron microscope (TEM) micrograph was obtained by analyzed using Hitachi (H-7500) electron microscope operating at 80 kV. To check the particle size distribution, particle size analyser (PSA) was performed using Malvern Zetasizer nanoseries (Nano-S90). 1H and 13C NMR spectra were measured on a model advance II (Bruker) instrument with frequency 300 MHz for 1H NMR and 100 MHz frequency for 13C NMR using TMS as the internal standard and CDCl3 as solvent. Microwave IFB 20PG2S, with power output-800 watt, operational frequency-2450 MHz has been used for synthesis of CuO NPs.
Dimedone and naphthol was supplied by Sigma Aldrich, copper chloride was obtained from Glaxo laboratory India and sodium hydroxide (NaOH) and benzaldehyde was supplied by Qualigens. p-Chlorobenzaldehyde, m-chlorobenzaldehyde, o-anisaldehyde, p-anisaldehyde, o-nitrobenzaldehyde and p-nitrobenzaldehyde, m-nitrobenzaldehyde, p-bromobenzaldehyde, p-cyanobenzaldehyde, p-methyl benzaldehyde were purchased from HiMedia. Ethanol was supplied by Changshu, Yangyuan Chemicals China. Purity of all chemicals was more than 98% and was used without further purification. Doubly distilled water was used for the synthesis of CuO NPs.
Table 2, 4b; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.85 (6H, s, 2 × CH3), 1.00 (6H, s, 2 × CH3), 1.97–2.10 (4H, q, 2 × CH2), 2.21–2.37 (4H, q, 2 × CH2), 3.67 (1H, s, OCH3), 4.70 (1H, s, CH), 6.60–7.26 (4H, m, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 26.89, 29.37, 29.63, 32.10, 41.06, 50.75, 55.11, 110.60, 113.95, 120.48, 127.77, 130.52, 132.21, 157.53, 162.21, 195.45.
Table 2, 4c; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.97 (6H, s, 2 × CH3), 1.08 (6H, s, 2 × CH3), 2.10–2.17 (4H, q, 2 × CH2), 2.40–2.42 (4H, q, 2 × CH2), 3.70 (3H, s, OCH3), 4.65 (1H, s, CH), 6.69–7.17 (4H, dd, Ar–H). 13C NMR (300 MHz, CDCl3); δC (ppm): 27.40, 29.35, 30.96, 32.20, 40.93, 50.78, 55.02, 113.50, 115.90, 129.31, 136.42, 158.03, 161.83, 196.10.
Table 2, 4d; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.98 (6H, s, 2 × CH3), 1.11 (6H, s, 2 × CH3), 2.10–2.24 (4H, q, 2 × CH2), 2.46 (4H, s, 2 × CH2), 4.76 (1H, s, CH), 7.41–8.08 (4H, dd, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 27.41, 29.42, 32.30, 40.99, 50.61, 114.75, 123.44, 129.39, 146.71, 151.23, 162.45, 195.43.
Table 2, 4e; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.86 (6H, s, 2 × CH3), 0.99 (6H, s, 2 × CH3), 2.04–2.06 (4H, q, 2 × CH2), 4.59 (1H, s, CH), 7.24–7.39 (4H, m, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 27.43, 29.44, 32.28, 32.52, 41.00, 50.63, 114.84, 129.35, 131.95, 162.37, 195.42.
Table 2, 4f; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.93 (6H, s, 2 × CH3), 1.06 (6H, s, 2 × CH3), 2.10–2.11 (4H, q, 2 × CH2), 2.37 (4H, s, 2 × CH2), 4.57 (1H, s, CH), 7.05–7.08 (2H, d, Ar–H), 7.23–7.26 (2H, d, Ar–H).13C NMR (100 MHz, CDCl3); δC (ppm): 27.50, 29.52, 31.58, 32, 27, 41.04, 50.70, 115.45, 120.49, 130.24, 131.22, 143.07, 161.77, 195.10.
Table 2, 4g; 1H NMR (300 MHz, CDCl3); δH (ppm): 0.97 (6H, s, 2 × CH3), 1.09 (6H, s, 2 × CH3), 2.13 2.15 (4H, q, 2 × CH2), 2.40–2.41 (4H, s, 2 × CH2), 4.62 (1H, s, CH), 7.13–7.15 (4H, m, Ar–H). 13C NMR (300 MHz, CDCl3); δC (ppm): 27.49, 29.53, 31.48, 32.27, 41.04, 50.70, 115.53, 128.29, 129.84, 132.31, 142.54, 161.75, 195.12.
Table 2, 4h; 1H NMR (300 MHz, CDCl3); δH (ppm): 1.03 (6H, s, 2 × CH3), 1.13 (6H, s, 2 × CH3), 2.20–2.21 (4H, q, 2 × CH2), 2.47 (4H, q, 2 × CH2), 4.69 (1H, s, CH), 7.09–7.27 (4H, m, Ar–H). 13C NMR (100 MHz, CDCl3; δC (ppm)): 27.51, 29.41, 31.75, 32.29, 41.00, 50.72, 115.30, 126.80, 127.15, 128.25, 129.24, 134.04, 146.04, 162.08, 195.45.
Table 2, 4i; 1H NMR (300 MHz, CDCl3); δH (ppm): 1.04 (6H, s, 2 × CH3), 1.10 (6H, s, 2 × CH3), 2.14–2.15 (4H, d), 2.24 (3H, s, CH3), 2.29 2.41 (4H, d), 4.62 (1H, s, CH), 6.94–6.97 (2H, d, Ar–H), 7.08 7.10 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 27.55, 29.61, 31.46, 32.30, 41.09, 50.80, 51.12, 116.07, 128.39, 128.86, 135.59, 141.15, 161.37, 163.06, 195.18.
Table 2, 5a; 1H NMR (300 MHz, CDCl3); δH (ppm): 6.44 (1H, s, CH), 7.24 (2H, s, Ar–H), 7.37–7.50 (9H, m), 7.74–7.79 (4H, m), 8.33–8.36 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 38.10, 117.39, 118.05, 122.73, 124.22, 126.77, 128.26, 128.54, 128.85, 131.14, 131.58, 145.02, 148.80.
Table 2, 5b; 1H NMR (300 MHz, CDCl3); δH (ppm): 2.12 (3H, s, CH3), 6.39 (1H, s, CH), 6.90–6.93 (2H, d. Ar–H), 7.33–7.38 (4H, m), 7.43–7.46 (2H, d, Ar–H), 7.50–7.53 (2H, d, Ar–H), 7.55–7.78 (4H, m), 8.32–8.35 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 21.02, 37.72, 117.50, 118.03, 122.79, 124.17, 126.71, 128.13, 128.74, 128.82, 129.25, 131.16, 131.59, 135.67, 142.18, 148.72.
Table 2, 5c; 1H NMR (300 MHz, CDCl3); δH (ppm): 3.54 (3H, s, OCH3), 6.37 (1H, s, CH), 6.58–6.60 (2H, d, Ar–H), 7.30–7.35 (4H, m), 7.38–7.40 (2H, d, Ar–H), 7.47–7.51 (2H, t, Ar–H), 7.69–7.75 (4H, m), 8.29–8.31 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 37.08, 55.05, 113.84, 117.53, 117.99, 122.67, 124.19, 126.74, 128.70, 128.78, 129.13, 131.07, 131.41, 148.69, 157.84.
Table 2, 5d; 1H NMR (300 MHz, CDCl3); δH (ppm): 6.53 (1H, s, CH), 7.34–7.38 (2H, t, Ar–H), 7.42–7.44 (2H, d, Ar–H), 7.50–7.54 (2H, t, Ar–H), 7.59–7.62 (2H, d, Ar–H), 7.75–7.79 (4H, m), 7.91–7.93 (2H, d, Ar–H), 8.19–8.22 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 37.86, 115.78, 118.06, 122.03, 123.86, 124.58, 127.19, 128.96, 129.06, 129.60, 131.09.
Table 2, 5e; 1H NMR (300 MHz. CDCl3); δH (ppm): 6.36 (1H, s, CH), 6.85–6.88 (1H, d), 6.95–6.99 (1H, t), 7.30–7.40 (6H, m), 7.47–7.51 (2H, t), 7.69–7.71 (4H, m), 8.21–8.23 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 37.75, 116.58, 118.08, 122.40, 124.38, 126.40, 126.74, 126.96, 128.33, 128.90, 129.16, 129.60, 131.06, 131.27, 134.42, 146.88, 148.79.
Table 2, 5f; 1H NMR (300 MHz, CDCl3); δH (ppm): 6.46 (1H, s, CH), 7.08–7.10 (2H, d, Ar–H), 7.39–7.48 (8H, m), 7.78–7.83 (4H, m) 8.29–8.32 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 37.37, 116.76, 118.01, 122.40, 124.36, 126.91, 128.63, 128.90, 129.08, 129.48, 131.08, 131.26, 132.09, 143.45, 148.72.
Table 2, 5g; 1H NMR (300 MHz, CDCl3); δH (ppm): 5.21 (1H, s, CH), 7.16–7.18 (2H, d, Ar–H), 7.29–7.40 (6H, m), 7.48–7.52 (2H, t, Ar–H), 7.71–7.76 (4H, m), 8.22–8.24 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 37.72, 115.89, 118.12, 121.69, 122.02, 122.71, 124.58, 127.24, 129.06, 129.49, 129.56, 131.04, 131.06, 134.2.
Table 2, 5h; 1H NMR (300 MHz, CDCl3); δH (ppm): 6.57 (1H, s, CH), 7.44–7.48 (4H, m), 7.50–7.53 (2H, d, Ar–H), 7.59–7.65 (4H, m), 7.84–7.88 (4H, m), 8.28–8.30 (2H, d, Ar–H). 13C NMR (100 MHz, CDCl3); δC (ppm): 26.03, 122.09, 124.65, 127.24, 128.92, 129.21, 129.66, 155.58.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c4ra07620f |
This journal is © The Royal Society of Chemistry 2014 |